(1)
Blaj, S.; Piso, P. Which Patient Is Going to Benefit from Surgical Cytoreduction With Intraperitoneal Chemotherapy (for Manifest Peritoneal metastases)?. Curr. Issues Pharm. Med. Sci. 2018, 30 (4), 207-210. https://doi.org/10.1515/cipms-2017-0040.